Navigation Links
Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
Date:5/7/2008

arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGF(beta)3) and velaglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM) (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on Shire's ADHD franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, including Shire plc's Annual Report on Form 10-
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
3. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
4. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
5. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
8. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
9. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced the resignation of Mr. Fuxiang Zhang ... effective immediately. Ms. Rebecca Yingnan Zhang has ... board of directors, effective immediately. Meanwhile, Ms. Zhang resigned ...
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "North ... Replacement, Digit Replacement, Elbow Replacement, Hip Replacement, ... 2019" report to their offering. ,     ... replacement was valued at $4,470.9 million in ...
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... MORRISTOWN, N.J. , July 12 ... confirmed that its subsidiary, Watson Laboratories, Inc., filed an ... and Drug Administration (FDA) seeking approval to market sevelamer ...  Watson,s sevelamer carbonate for oral suspension product is the ...
... BETHESDA, Md. , July 12 The Hanger ... generous donation of $75,000 from Grapes for Humanity/US, ... dollars in support of landmine survivors and innocent victims of ... used by the Hanger Ivan R. Sabel Foundation to continue ...
Cached Medicine Technology:Watson Confirms Renvela® for Oral Suspension Patent Challenge 2Watson Confirms Renvela® for Oral Suspension Patent Challenge 3Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US 2
(Date:5/22/2015)... Co founders Greenlee and James Chapko, DDS ... dentists to immediately deliver fully integrated dental implant services to ... the medical surgeon. , The Center, whose name is ... dentists from placing dental implants. These 6 roadblocks can ... the surgical placement of dental implants into his or her ...
(Date:5/22/2015)... 2015 Puritan Medical Products, a ... medical, diagnostic, environmental, and forensics industries celebrates 96 ... in the US. At a time when countless ... US, Puritan remains committed to designing and manufacturing ... Maine facility. , Since 1919, Puritan has focused ...
(Date:5/22/2015)... 22, 2015 Javon Bea Mercy ... recognized for providing the highest quality emergency care services, ... care decision-making,” said Javon R. Bea, President and CEO ... of our employee/partners to care for and respond to ... do not apply for this award, but are selected ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... distributor of patented products, launches the Troll Motor Guide, ... convenient way of boating. , "The recreational boating industry ... Scott J. Cooper, CEO and Creative Director of ... water in record numbers and predicts continued steady growth ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Absolute Exhibits, ... a highly interactive, state-of-the-art website that is filled with ... trade show resource information. With its original and inventive ... as practical. The website shows hundred of pictures of ... show floor. This is not an exhibit rendering site, ...
Breaking Medicine News(10 mins):Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:New Convention and City Travel Guides Within the Absolute Exhibits’ Website 2
... YORK, April 9 A new study conducted at ... the Lipton Institute of Tea, is the first to ... - simultaneously increased blood vessel reactivity and reduced both ... profile that is consistent with maintaining heart health.Using a ...
... plan for its Barcode Inventory, Asset, Evidence and Item Tracking systems which ... (60) month financing. These finance options are designed to reduce the ... more efficient and effective. , ... San Jose, CA (PRWEB) April 9, ...
... Revenue Services simplifies physician practices and makes them ... for clients who demand results by securing client ... provide the right tools to providers, offices that ... guaranteeing less billing and coding errors, which results ...
... was formed in response to the FDA,s position that the patient,s ... such. The patient group believes that this misclassification of adult ... any significant patient safety. , ... Broomfield, Colorado (PRWEB) ...
... vice versa is unclear, expert says, , , THURSDAY, April ... on by lack of team spirit increases worker depression ... for relief, a new study finds. , Given the ... with people afraid of losing their jobs and uncertain ...
... Manufacture of the Axxent(R) SystemSUNNYVALE, Calif., April 9 ... field of micro-miniature X-ray sources for medical treatment, ... medical device license by the Medical Devices Bureau ... Axxent(R) Electronic Brachytherapy System. The proprietary Electronic Brachytherapy ...
Cached Medicine News:Health News:New Research Suggests Drinking as Little as One Cup of Black Tea Per Day May Help Maintain Cardiovascular Function and Heart Health 2Health News:New Research Suggests Drinking as Little as One Cup of Black Tea Per Day May Help Maintain Cardiovascular Function and Heart Health 3Health News:New Research Suggests Drinking as Little as One Cup of Black Tea Per Day May Help Maintain Cardiovascular Function and Heart Health 4Health News:ASAP Systems now Offers Flexible Payment Options for its Barcode Inventory, Asset and Evidence Tracking Solutions Through a Strategic Microsoft Financing™ Partnership 2Health News:Patient Movement Forms in Opposition to FDA Position that the Patient's Own Stem Cells are Drugs 2Health News:Patient Movement Forms in Opposition to FDA Position that the Patient's Own Stem Cells are Drugs 3Health News:As Work Stress Rises, So May Depression 2Health News:As Work Stress Rises, So May Depression 3Health News:Xoft Receives Health Canada Regulatory Approval for the Axxent(R) Electronic Brachytherapy System 2Health News:Xoft Receives Health Canada Regulatory Approval for the Axxent(R) Electronic Brachytherapy System 3
... 2000 is a software driven, PC-based 12-lead ... The BioStress 2000 program is easy to ... ECG strorage and retrieval and can be ... 2000 allows a wide range of selective ...
The Urchin heart positioner provides excellent access to target coronaries while minimizing hemodynamic instability...
... System II which includes both the Octopus4 ... The Starfish2 heart positioner provides excellent access ... The new Octopus System II (Octopus4 ... of use and performance that make it ...
... Medtronic's OctoBase Retractor system is ... sternotomy beating heart CAB procedures. ... countless Octopus stabilizer mounting options. ... allows for multiple blade configurations ...
Medicine Products: